Global Transcranial Magnetic Stimulators (TMS) Market Research Report 2012-2023
- HEY2852195
- 110 Pages
- December 2018
- Medical Devices
Transcranial magnetic stimulation (TMS) is a magnetic method used to stimulate small regions of the brain. During a TMS procedure, a magnetic field generator, or "coil", is placed near the head of the person receiving the Tinnitus. The coil produces small electric currents in the region of the brain just under the coil via electromagnetic induction. The coil is connected to a pulse generator, or stimulator, that delivers electric current to the coil.
The global Transcranial Magnetic Stimulators (TMS) market will reach xxx Million USD in 2017 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
STMS
PTMS
RTMS
nTMS
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Neuronetics
Yiruide
Magstim
Brainsway
Neurosoft
eNeura
MagVenture
Remed
Nexstim
Dr. Langer Medical
MAG & More
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Depression
Tinnitus
Alzheimer
Parkinson's Disease
Psychiatric Disorders
Headache
Stroke
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 STMS
1.2.1.2 PTMS
1.2.1.3 RTMS
1.2.1.4 nTMS
1.2.2 by Application
1.2.2.1 Depression
1.2.2.2 Tinnitus
1.2.2.3 Alzheimer
1.2.2.4 Parkinson's Disease
1.2.2.5 Psychiatric Disorders
1.2.2.6 Headache
1.2.2.7 Stroke
1.2.2.8 Others
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 STMS Market, 2012-2017
4.1.2 PTMS Market, 2012-2017
4.1.3 RTMS Market, 2012-2017
4.1.4 nTMS Market, 2012-2017
4.2 Market Forecast
4.2.1 STMS Market Forecast, 2018-2023
4.2.2 PTMS Market Forecast, 2018-2023
4.2.3 RTMS Market Forecast, 2018-2023
4.2.4 nTMS Market Forecast, 2018-2023
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Depression Market, 2012-2017
5.1.2 Tinnitus Market, 2012-2017
5.1.3 Alzheimer Market, 2012-2017
5.1.4 Parkinson's Disease Market, 2012-2017
5.1.5 Psychiatric Disorders Market, 2012-2017
5.1.6 Headache Market, 2012-2017
5.1.7 Stroke Market, 2012-2017
5.1.8 Others Market, 2012-2017
5.2 Market Forecast
5.2.1 Depression Market Forecast, 2018-2023
5.2.2 Tinnitus Market Forecast, 2018-2023
5.2.3 Alzheimer Market Forecast, 2018-2023
5.2.4 Parkinson's Disease Market Forecast, 2018-2023
5.2.5 Psychiatric Disorders Market Forecast, 2018-2023
5.2.6 Headache Market Forecast, 2018-2023
5.2.7 Stroke Market Forecast, 2018-2023
5.2.8 Others Market Forecast, 2018-2023
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2012-2017
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2012-2017
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2012-2017
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2012-2017
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2012-2017
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2018-2023
6.2.2 North America Market Forecast, 2018-2023
6.2.3 Europe Market Forecast, 2018-2023
6.2.4 South America Market Forecast, 2018-2023
6.2.5 Middle East & Africa Market Forecast, 2018-2023
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Neuronetics
8.1.2 Profile
8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.2 Yiruide
8.2.1 Profile
8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.3 Magstim
8.3.1 Profile
8.3.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.4 Brainsway
8.4.1 Profile
8.4.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.5 Neurosoft
8.5.1 Profile
8.5.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.6 eNeura
8.6.1 Profile
8.6.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.7 MagVenture
8.7.1 Profile
8.7.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.8 Remed
8.8.1 Profile
8.8.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.9 Nexstim
8.9.1 Profile
8.9.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.10 Dr. Langer Medical
8.10.1 Profile
8.10.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.11 MAG & More
9 Conclusion
Table Products Segment of Transcranial Magnetic Stimulators (TMS)
Table STMS Overview
Table PTMS Overview
Table RTMS Overview
Table nTMS Overview
Table Global Transcranial Magnetic Stimulators (TMS) Market by Type, 2011-2022 (USD Million)
Table Application Segment of Transcranial Magnetic Stimulators (TMS)
Table Depression Overview
Table Tinnitus Overview
Table Alzheimer Overview
Table Parkinson's Disease Overview
Table Psychiatric Disorders Overview
Table Headache Overview
Table Stroke Overview
Table Others Overview
Table Global Transcranial Magnetic Stimulators (TMS) Market by Application, 2011-2022 (USD Million)
Table Global Transcranial Magnetic Stimulators (TMS) Market by Region, 2011-2022 (USD Million)
Table Cost of Transcranial Magnetic Stimulators (TMS)
Table Market Dynamics
Table Policy of Transcranial Magnetic Stimulators (TMS)
Table GDP of Major Countries
Table STMS CAGR by Revenue and Volume, 2012-2017
Table PTMS CAGR by Revenue and Volume, 2012-2017
Table RTMS CAGR by Revenue and Volume, 2012-2017
Table nTMS CAGR by Revenue and Volume, 2012-2017
Table STMS CAGR by Revenue and Volume, 2012-2022
Table PTMS CAGR by Revenue and Volume, 2012-2022
Table RTMS CAGR by Revenue and Volume, 2012-2022
Table nTMS CAGR by Revenue and Volume, 2012-2022
Table Depression CAGR by Revenue and Volume, 2012-2017
Table Tinnitus CAGR by Revenue and Volume, 2012-2017
Table Alzheimer CAGR by Revenue and Volume, 2012-2017
Table Parkinson's Disease CAGR by Revenue and Volume, 2012-2017
Table Psychiatric Disorders CAGR by Revenue and Volume, 2012-2017
Table Headache CAGR by Revenue and Volume, 2012-2017
Table Stroke CAGR by Revenue and Volume, 2012-2017
Table Others CAGR by Revenue and Volume, 2012-2017
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
